Jon Marc Wigginton, Senior VP Clinical Development & CMO at MACROGENICS INC (MGNX), sold 5,000 shares at $27.22 ($136K) on 2016-07-01, disclosed to the SEC on 2016-07-06.
Open-market sale of $136k MGNX by Senior VP Clinical Development & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MGNX | SELL | 2017-10-26 | $200K | — | Filing → |
| MGNX | SELL | 2017-06-06 | $100K | — | Filing → |
| MGNX | SELL | 2017-04-20 | $300K | — | Filing → |